Bernstein sees the overall 2Q26 chemicals sector as resilient, with Akzo Nobel as its top tactical preference
AI summary card
Bernstein sees the overall 2Q26 chemicals sector as resilient, with Akzo Nobel as its top tactical preference
The report believes there will not be many surprises among covered chemicals companies in 2Q26, with the key opportunity being overly pessimistic expectations for an Akzo Nobel guidance cut, while Air Liquide growth expectations and Solvay downside risks need to be managed.
- Bernstein expects overall 2Q26 performance for covered companies to be mostly resilient, and after BASF's early disclosure, the likelihood of further major positive surprises across the sector is limited.
- The highest-conviction tactical trade is to go long Akzo Nobel, because the market broadly expects it to cut FY26 EBITDA guidance, but Bernstein believes this expectation is overly pessimistic.
- Air Liquide's fundamentals are still considered resilient, but the market's expectations for accelerating comparable growth in 2H26 may be too optimistic, especially in the Large Industries business.
- Solvay's earnings release has a negatively skewed risk-reward profile; even if 2Q26 EBITDA meets expectations, full-year guidance could still come under pressure if demand, raw materials, or soda ash pricing deteriorate.
- Model updates are generally small, but several companies saw mechanically or valuation-multiple-driven target price adjustments, including Air Liquide, Akzo Nobel, Arkema, Borouge, Clariant, Linde, Solvay, and Syensqo.
Report interpretation
Overview
This is a Bernstein preview report on 2Q26 earnings in the chemicals sector, covering multiple subsectors including industrial gases, coatings, and industrial chemicals. The report's core judgment is that covered companies' earnings should generally be fairly resilient, but after BASF's early disclosure, upside surprise potential during the results period is limited; U.S. industrial gas companies may still modestly raise guidance, but the average magnitude is expected to be below 1%. The report's clearest short-term tactical view is to favor Akzo Nobel into earnings, while warning that market expectations need to be managed for Air Liquide and Solvay communications.
Core views
There are three core views. First, Akzo Nobel is the highest-conviction tactical long idea, as Bernstein believes the market is overly pessimistic about a cut to its FY26 EBITDA guidance because volume resilience remains intact and roughly 2% pricing can offset raw material cost pressure. Second, Air Liquide's fundamentals and profitability are still viewed as healthy, but market expectations for accelerating comparable growth in 2H26 may be too high, with Large Industries lacking a clear demand inflection in Europe and Asia. Third, Solvay has a negatively skewed risk-reward profile: although Bernstein models 2Q26 EBITDA as broadly in line with expectations, even a slight miss could trigger investor concerns about the achievability of the low end of full-year guidance.
Analysis framework
The report uses an earnings preview framework, comparing company guidance, Bernstein forecasts, sell-side consensus, comparable growth, EBITDA/EPS, margins, raw material costs, pricing power, and target price changes. The analytical focus is not simply whether 2Q26 beats expectations, but rather the direction of post-results management guidance, market expectation revisions, and share price reactions.
Methodology notes
Assess potential upside surprise or downside risk around earnings releases by comparing Bernstein forecasts, company guidance, and Bloomberg or Visible Alpha consensus expectations.
The report compares key metrics for 2Q26, 3Q26, and FY26 across industrial gas, coatings, and industrial chemicals companies to identify names where market expectations are too high or too low.
Assess likely share price reactions to guidance, margins, and growth commentary ahead of earnings releases.
Akzo Nobel is listed as the highest-conviction tactical long because the report believes the market has overdiscounted guidance-cut risk, while Solvay has negatively skewed risk-reward due to fragile guidance credibility.
Compare raw material inflation, price increases, and companies' historical pricing power to judge margin and guidance resilience.
For Akzo Nobel, the report believes high-single-digit to low-double-digit raw material cost increases in 2Q-4Q26 can be offset by roughly 2% pricing, so there is no need to rush to cut full-year EBITDA guidance.
Asset mapping & comparison
Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).
- Akzo NobelHighest-conviction tactical long idea
- Strengths
- Volume resilience, pricing power, and raw material cost pass-through support maintaining FY26 EBITDA guidance; Bernstein's 2026E EBITDA is €1.476bn.
- Weaknesses
- The medium-term outlook is uncertain, and raw material inflation remains the main margin pressure.
- Comparison
- Relative to market consensus, Bernstein believes expectations for a guidance cut are overly pessimistic.
- Risks
- If demand weakens materially or pricing is insufficient to offset raw material increases, the case for maintaining guidance would weaken.
- Air LiquideResilient fundamentals but growth expectations need managing
- Strengths
- Margin improvement and cost initiatives can offset part of the impact if growth comes in below expectations; Bernstein expects 2H26 OIR margin improvement of +130bps.
- Weaknesses
- Large Industries lacks a clear demand inflection in Europe and Asia, and expectations for accelerating comparable growth in 2H26 may be too high.
- Comparison
- Earnings forecasts and FY26 profitability expectations are broadly close to consensus, but the growth path is below the market's more optimistic assumptions.
- Risks
- If H1 results or growth commentary are interpreted as conservative, there could be a short-term sell-off similar to the one after 1Q26.
- SolvayNegatively skewed risk-reward
- Strengths
- If the Sadara peroxide plant restarts in Q4 and raw material inflation does not worsen further, the company may still reach the low end of 2026 guidance.
- Weaknesses
- The margin of safety around full-year guidance is thin, and in a weak demand and inflationary environment, even a modest beat may not ease market concerns.
- Comparison
- Bernstein models 2Q26 EBITDA as broadly in line with expectations, but does not include further deterioration in demand or soda ash prices in the base case.
- Risks
- A slight 2Q26 miss, weaker demand, softer soda ash prices, or another sharp rise in raw material inflation could all lead to cuts in valuation and earnings forecasts.
- LindeOutperform-rated covered name
- Strengths
- High-quality industrial gas business with strong earnings growth and margin resilience.
- Weaknesses
- The report slightly lowers 2026 and 2027 EPS, reflecting somewhat weaker-than-expected 4Q26 growth.
- Comparison
- It remains among Bernstein's more preferred names within chemicals coverage.
- Risks
- Slower growth would limit valuation upside, with the target price lowered from $561 to $559.
- Air ProductsOutperform-rated covered name
- Strengths
- There is still potential for a guidance upgrade, and the FY26 EPS forecast was modestly raised.
- Weaknesses
- The market hurdle is high, and earnings need to deliver on guidance improvement.
- Comparison
- Within industrial gases, it is another high-expectation name alongside Linde.
- Risks
- If 3QFY26 or FY26 guidance is not raised, it could trigger a valuation pullback.
- SyensqoOutperform-rated covered name
- Strengths
- A recovery in electronics can support base EBITDA reaching guidance of about €1.1bn.
- Weaknesses
- It still requires improvement in some businesses to support the full-year path.
- Comparison
- Compared with Solvay, the report has greater confidence in the components supporting Syensqo's ability to meet guidance.
- Risks
- If the electronics recovery is insufficient or other end markets weaken further, the EBITDA improvement path could come under pressure.
Key data
- Akzo Nobel 2026E EBITDA€1.476bnBernstein's forecast is broadly in line with the company's €1.47bn+ guidance and above company-defined consensus of €1.420bn, Bloomberg €1.424bn, and Visible Alpha €1.423bn.
- Akzo Nobel target price€60The target price was raised from €59 to €60, while the 2026 EBITDA forecast remains around €1.48bn.
- Air Liquide target price€189Due to a mechanical adjustment from the free share distribution, the target price was lowered from €207 to €189, with only minor changes to the fundamental model.
- Air Liquide 2H26 OIR margin improvement+130bpsBernstein believes that even if growth comes in slightly below consensus, the pricing environment and cost initiatives can still support margin improvement.
- Air Products target price$345FY26 EPS forecast was raised by 3 cents, FY27 EPS was unchanged, and the target price was increased from $344 to $345.
- Arkema target price€612026 and 2027 EBITDA forecasts were each cut by 1%, the target multiple fell from 6.4x to 6.1x, and the target price was reduced from €68 to €61.
- Solvay 2026E EBITDA€774mThe forecast was cut by €6m, remaining slightly above the low end of guidance; the target price was lowered from €26.60 to €26.20.
- Syensqo target price€71The 2026 EBITDA forecast was raised by €7m, and the target price was increased from €70 to €71.
Impact & implications
The investment implication is that the 2Q26 results period in chemicals is better suited to company-specific relative trades rather than simply betting on a broad sector rally. Akzo Nobel may benefit from a repricing of its ability to maintain guidance and pass through costs; if Air Liquide's growth commentary falls short of market expectations for 2H26 acceleration, the stock may come under short-term pressure but with limited fundamental risk; Solvay's full-year guidance has a thin margin of safety, and if demand, soda ash pricing, or raw material inflation deteriorate further, the market may quickly cut expectations.
Risks
- European chemicals sentiment indicators remain weak, with IFO surveys related to coatings, plastics, and basic chemicals showing a demand environment lacking momentum.
- If raw material cost inflation is higher than expected, it could erode margins in coatings and industrial chemicals.
- If market expectations for accelerating Air Liquide comparable growth in 2H26 are not met, it could cause short-term share price volatility.
- Solvay depends on the Sadara peroxide plant restart, stable demand, and no further deterioration in soda ash prices.
- Geopolitical and logistics disruptions are affecting companies such as Borouge, and the report has cut its 2026E and 2027E EBITDA by 14% and 3%, respectively.
What to watch
- Whether Akzo Nobel maintains FY26 EBITDA guidance of €1.47bn+ and how management describes raw material inflation and pricing pass-through.
- Regional demand in Large Industries, 2H comparable growth commentary, and the magnitude of margin improvement in Air Liquide's H1 results.
- Whether Solvay 2Q26 EBITDA comes in near or below expectations, and whether management can still support the low end of full-year guidance.
- Whether U.S. industrial gas companies modestly raise guidance as expected, and whether the magnitude is below or above 1%.
- Whether European chemicals sentiment indicators, soda ash prices, raw material prices, and end demand continue to deteriorate.